Chemokines and cytokines in immunotherapy of melanoma and other tumors: from biomarkers to therapeutic targets
Chemokines and cytokines represent an emerging field of immunotherapy research. They are responsible for the crosstalk and chemoattraction of immune cells and tumor cells. For instance, CXCL9/10/11 chemoattract effector CD8+ T cells to the tumor microenvironment, making an argument for their promisi...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
13 June 2024
|
| In: |
International journal of molecular sciences
Year: 2024, Jahrgang: 25, Heft: 12, Pages: 1-17 |
| ISSN: | 1422-0067 |
| DOI: | 10.3390/ijms25126532 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.3390/ijms25126532 Verlag, kostenfrei, Volltext: https://www.mdpi.com/1422-0067/25/12/6532 |
| Verfasserangaben: | Robin Reschke, Alexander H. Enk and Jessica C. Hassel |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1916150381 | ||
| 003 | DE-627 | ||
| 005 | 20250716225728.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250203s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/ijms25126532 |2 doi | |
| 035 | |a (DE-627)1916150381 | ||
| 035 | |a (DE-599)KXP1916150381 | ||
| 035 | |a (OCoLC)1528018373 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Reschke, Robin Niklas |d 1989- |e VerfasserIn |0 (DE-588)113859038X |0 (DE-627)896092011 |0 (DE-576)492596956 |4 aut | |
| 245 | 1 | 0 | |a Chemokines and cytokines in immunotherapy of melanoma and other tumors |b from biomarkers to therapeutic targets |c Robin Reschke, Alexander H. Enk and Jessica C. Hassel |
| 264 | 1 | |c 13 June 2024 | |
| 300 | |b Illustrationen | ||
| 300 | |a 17 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 03.02.2025 | ||
| 520 | |a Chemokines and cytokines represent an emerging field of immunotherapy research. They are responsible for the crosstalk and chemoattraction of immune cells and tumor cells. For instance, CXCL9/10/11 chemoattract effector CD8+ T cells to the tumor microenvironment, making an argument for their promising role as biomarkers for a favorable outcome. The cytokine Interleukin-15 (IL-15) can promote the chemokine expression of CXCR3 ligands but also XCL1, contributing to an important DC-T cell interaction. Recruited cytotoxic T cells can be clonally expanded by IL-2. Delivering or inducing these chemokines and cytokines can result in tumor shrinkage and might synergize with immune checkpoint inhibition. In addition, blocking specific chemokine and cytokine receptors such as CCR2, CCR4 or Il-6R can reduce the recruitment of tumor-associated macrophages (TAMs), myeloid-derived suppressor cells (MDSCs) or regulatory T cells (Tregs). Efforts to target these chemokines and cytokines have the potential to personalize cancer immunotherapy further and address patients that are not yet responsive because of immune cell exclusion. Targeting cytokines such as IL-6 and IL-15 is currently being evaluated in clinical trials in combination with immune checkpoint-blocking antibodies for the treatment of metastatic melanoma. The improved overall survival of melanoma patients might outweigh potential risks such as autoimmunity. However, off-target toxicity needs to be elucidated. | ||
| 650 | 4 | |a chemokines | |
| 650 | 4 | |a cytokines | |
| 650 | 4 | |a immunotherapy | |
| 650 | 4 | |a tumor microenvironment | |
| 700 | 1 | |a Enk, Alexander |d 1963- |e VerfasserIn |0 (DE-588)1032757140 |0 (DE-627)739272535 |0 (DE-576)166173517 |4 aut | |
| 700 | 1 | |a Hassel, Jessica C. |d 1975- |e VerfasserIn |0 (DE-588)129790702 |0 (DE-627)480399069 |0 (DE-576)29783715X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of molecular sciences |d Basel : Molecular Diversity Preservation International, 2000 |g 25(2024), 12, Artikel-ID 6532, Seite 1-17 |h Online-Ressource |w (DE-627)316340715 |w (DE-600)2019364-6 |w (DE-576)281194653 |x 1422-0067 |7 nnas |a Chemokines and cytokines in immunotherapy of melanoma and other tumors from biomarkers to therapeutic targets |
| 773 | 1 | 8 | |g volume:25 |g year:2024 |g number:12 |g elocationid:6532 |g pages:1-17 |g extent:17 |a Chemokines and cytokines in immunotherapy of melanoma and other tumors from biomarkers to therapeutic targets |
| 856 | 4 | 0 | |u https://doi.org/10.3390/ijms25126532 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.mdpi.com/1422-0067/25/12/6532 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250203 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 129790702 |a Hassel, Jessica C. |m 129790702:Hassel, Jessica C. |d 910000 |d 911300 |d 50000 |e 910000PH129790702 |e 911300PH129790702 |e 50000PH129790702 |k 0/910000/ |k 1/910000/911300/ |k 0/50000/ |p 3 |y j | ||
| 998 | |g 1032757140 |a Enk, Alexander |m 1032757140:Enk, Alexander |d 910000 |d 911300 |e 910000PE1032757140 |e 911300PE1032757140 |k 0/910000/ |k 1/910000/911300/ |p 2 | ||
| 998 | |g 113859038X |a Reschke, Robin Niklas |m 113859038X:Reschke, Robin Niklas |d 910000 |d 911300 |e 910000PR113859038X |e 911300PR113859038X |k 0/910000/ |k 1/910000/911300/ |p 1 |x j | ||
| 999 | |a KXP-PPN1916150381 |e 4659933555 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"subtitle":"from biomarkers to therapeutic targets","title_sort":"Chemokines and cytokines in immunotherapy of melanoma and other tumors","title":"Chemokines and cytokines in immunotherapy of melanoma and other tumors"}],"person":[{"family":"Reschke","display":"Reschke, Robin Niklas","given":"Robin Niklas","role":"aut"},{"family":"Enk","given":"Alexander","display":"Enk, Alexander","role":"aut"},{"family":"Hassel","role":"aut","display":"Hassel, Jessica C.","given":"Jessica C."}],"physDesc":[{"extent":"17 S.","noteIll":"Illustrationen"}],"id":{"eki":["1916150381"],"doi":["10.3390/ijms25126532"]},"language":["eng"],"name":{"displayForm":["Robin Reschke, Alexander H. Enk and Jessica C. Hassel"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1916150381","relHost":[{"recId":"316340715","origin":[{"publisherPlace":"Basel","publisher":"Molecular Diversity Preservation International","dateIssuedDisp":"2000-","dateIssuedKey":"2000"}],"note":["Gesehen am 17.09.20"],"pubHistory":["1.2000 -"],"id":{"eki":["316340715"],"zdb":["2019364-6"],"issn":["1422-0067","1661-6596"]},"language":["eng"],"titleAlt":[{"title":"IJMS"}],"part":{"extent":"17","volume":"25","issue":"12","pages":"1-17","year":"2024","text":"25(2024), 12, Artikel-ID 6532, Seite 1-17"},"title":[{"title":"International journal of molecular sciences","title_sort":"International journal of molecular sciences"}],"disp":"Chemokines and cytokines in immunotherapy of melanoma and other tumors from biomarkers to therapeutic targetsInternational journal of molecular sciences","physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"}}],"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"13 June 2024"}],"note":["Gesehen am 03.02.2025"]} | ||
| SRT | |a RESCHKEROBCHEMOKINES1320 | ||